Breast cancers lacking estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) overexpression/amplification are known as “triple negative breast cancer” (TNBC) [2]. This evidence concerns the gene ERBB2 and breast carcinoma.